Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013229807> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2013229807 endingPage "167" @default.
- W2013229807 startingPage "161" @default.
- W2013229807 abstract "In a prospective randomized and double-blind cross-over study, a new antiemetic regimen consisting of betamethasone (1 x 8 mg) and dixyrazine (a phenothiazine derivative) (4 x 10 mg) was compared with a standard high-dose metoclopramide (4 x 1 mg/kg) schedule for antiemetic treatment in doxorubicin and cisplatin chemotherapy. 100 consecutive patients (62 without prior experience of chemotherapy and 38 with prior experience) entered the study and were followed during 1-4 courses of chemotherapy. Effect and side effect parameters were recorded on questionnaires for patients and nurses using the visual analog scale for quantification. The correlation between the two ways of recording (self-scoring versus recording by nursing staff) was very high, both for effect variables (nausea and vomiting) and the adverse reactions (sedation and extrapyramidal reactions). The median number of courses per patient was 3.0 (range 1-4) and altogether 299 courses were studied. Full emetic protection was achieved in 58% with betamethasone-dixyrazine and in 34% with high-dose metoclopramide regardless of prior patient experience or the cytostatic agents administered. With doxorubicin regimens, betamethasone-dixyrazine gave full protection in 80% compared to 40% for metoclopramide. Cisplatin regimens were a greater challenge and protection against nausea and vomiting was achieved only in 27% with betamethasone-dixyrazine and in 18% with metoclopramide. Adverse reactions were a significant problem with metoclopramide: restlessness 33%, akathisia 19%, parkinsonism 16%, and acute dystonia 3%. Sedation was the same with the two regimens (80%)." @default.
- W2013229807 created "2016-06-24" @default.
- W2013229807 creator A5014034220 @default.
- W2013229807 creator A5040170577 @default.
- W2013229807 creator A5073548605 @default.
- W2013229807 creator A5076286133 @default.
- W2013229807 date "1989-06-01" @default.
- W2013229807 modified "2023-09-27" @default.
- W2013229807 title "Betamethasone-dixyrazine combination versus high-dose metoclopramide as antiemetic treatment in doxorubicin and cisplatin chemotherapy" @default.
- W2013229807 cites W179778799 @default.
- W2013229807 cites W1833636635 @default.
- W2013229807 cites W184870987 @default.
- W2013229807 cites W1966650548 @default.
- W2013229807 cites W1984568013 @default.
- W2013229807 cites W1993070327 @default.
- W2013229807 cites W2034846984 @default.
- W2013229807 cites W2039228293 @default.
- W2013229807 cites W2058614547 @default.
- W2013229807 cites W2103190374 @default.
- W2013229807 cites W2415235540 @default.
- W2013229807 doi "https://doi.org/10.1016/0167-8140(89)90130-8" @default.
- W2013229807 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2762589" @default.
- W2013229807 hasPublicationYear "1989" @default.
- W2013229807 type Work @default.
- W2013229807 sameAs 2013229807 @default.
- W2013229807 citedByCount "9" @default.
- W2013229807 crossrefType "journal-article" @default.
- W2013229807 hasAuthorship W2013229807A5014034220 @default.
- W2013229807 hasAuthorship W2013229807A5040170577 @default.
- W2013229807 hasAuthorship W2013229807A5073548605 @default.
- W2013229807 hasAuthorship W2013229807A5076286133 @default.
- W2013229807 hasConcept C126322002 @default.
- W2013229807 hasConcept C141071460 @default.
- W2013229807 hasConcept C197934379 @default.
- W2013229807 hasConcept C2776694085 @default.
- W2013229807 hasConcept C2776814716 @default.
- W2013229807 hasConcept C2778479196 @default.
- W2013229807 hasConcept C2780580376 @default.
- W2013229807 hasConcept C2780852908 @default.
- W2013229807 hasConcept C2780884295 @default.
- W2013229807 hasConcept C2781162121 @default.
- W2013229807 hasConcept C2781324269 @default.
- W2013229807 hasConcept C42219234 @default.
- W2013229807 hasConcept C71924100 @default.
- W2013229807 hasConceptScore W2013229807C126322002 @default.
- W2013229807 hasConceptScore W2013229807C141071460 @default.
- W2013229807 hasConceptScore W2013229807C197934379 @default.
- W2013229807 hasConceptScore W2013229807C2776694085 @default.
- W2013229807 hasConceptScore W2013229807C2776814716 @default.
- W2013229807 hasConceptScore W2013229807C2778479196 @default.
- W2013229807 hasConceptScore W2013229807C2780580376 @default.
- W2013229807 hasConceptScore W2013229807C2780852908 @default.
- W2013229807 hasConceptScore W2013229807C2780884295 @default.
- W2013229807 hasConceptScore W2013229807C2781162121 @default.
- W2013229807 hasConceptScore W2013229807C2781324269 @default.
- W2013229807 hasConceptScore W2013229807C42219234 @default.
- W2013229807 hasConceptScore W2013229807C71924100 @default.
- W2013229807 hasIssue "2" @default.
- W2013229807 hasLocation W20132298071 @default.
- W2013229807 hasLocation W20132298072 @default.
- W2013229807 hasOpenAccess W2013229807 @default.
- W2013229807 hasPrimaryLocation W20132298071 @default.
- W2013229807 hasRelatedWork W161558341 @default.
- W2013229807 hasRelatedWork W1901462095 @default.
- W2013229807 hasRelatedWork W2020030012 @default.
- W2013229807 hasRelatedWork W2092949011 @default.
- W2013229807 hasRelatedWork W2146379668 @default.
- W2013229807 hasRelatedWork W2164832682 @default.
- W2013229807 hasRelatedWork W2396862624 @default.
- W2013229807 hasRelatedWork W2419640436 @default.
- W2013229807 hasRelatedWork W2460840039 @default.
- W2013229807 hasRelatedWork W99764709 @default.
- W2013229807 hasVolume "15" @default.
- W2013229807 isParatext "false" @default.
- W2013229807 isRetracted "false" @default.
- W2013229807 magId "2013229807" @default.
- W2013229807 workType "article" @default.